The healthcare solutions distributor will soon have a new top leader for the first time in over 35 years as Stanley Bergman — ...

Stanley Bergman, CEO of dental supplier Henry Schein, is stepping down from his position at the end of 2025.  Mr. Bergman has spent more than 45 years at the company, including more than 35 years as ...

The company's next-generation sequencing-based test is used to aid the detection of cancers in patients with indeterminate ...

Henry Schein, Inc. (NASDAQ:HSIC) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company announced the completion of a $250 million strategic investment by funds ...

Henry Schein Reports 1Q Financial Results On May 9, Henry Schein reported 1Q net sales of $3.1 billion, down 3.8% year-over-year. The sales decline was caused by a decrease in the sales of personal ...

Welcome to Henry Schein's First Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session.

Medical supplies distributor Henry Schein Inc on Monday missed first-quarter revenue estimates, hurt by muted demand for its dental products amid rising inflation.

Summary Henry Schein is the world's largest provider of healthcare products and services for office-based dental and medical practitioners, showing consistent growth through acquisitions.

Henry Schein Inc (HSIC) reports a 5.8% increase in global sales and significant operating margin improvements, despite facing headwinds in the medical and orthodontic sectors.

Henry Schein also donated essential health care supplies to its partner relief organizations operating on the ground. In fact, the company already had an event planned to pack hygiene kits to give to ...

Henry Schein’s third-quarter global dental segment sales were $1.9 billion, down 1.6%, and medical segment sales increased by 2.9% (down 4.8% internally) to $1.1 billion.